A26G (p.Ala26Gly) variant of GFAP (Glial fibrillary acidic protein)

A26G (p.Ala26Gly) in GFAP (Glial fibrillary acidic protein) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.35 / 1. The record also includes population frequency data.

A26G (p.Ala26Gly) variant details